NETs (DBCOND0124523)

Identifiers

Synonyms

NET

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06632860	A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors	No drug interventions	diagnostic	0	recruiting
NCT04175457	The Acute Effects of E-cigarette Inhalation on Vascular Function, Microcirculation and Thrombosis	No drug interventions	other	Not Available	completed
NCT04550026	Cardiovascular Effects of Heated Tobacco Products (HTP)	No drug interventions	other	Not Available	completed
NCT06441331	Phase I Trial to Determine the Dose and Evaluate the PK of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors	Edotreotide Lutetium Lu-177 Lutetium Lu177 Edotreotide	treatment	1	not_yet_recruiting
NCT05997056	Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors	Sirolimus	treatment	2	recruiting
NCT01262235	A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients	No drug interventions	treatment	1 / 2	completed